Repurposing Alzheimer’s disease medications—systemic cholinesterase inhibitors—for the treatment of dry eye syndrome, glaucoma, and age-related macular degeneration
Saved in:
| Main Authors: | Shilpa Rajagopal, Pranati Ahuja, Valerie Quach, Cody Luong, Mukaila A. Raji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-05-01
|
| Series: | Therapeutic Advances in Ophthalmology |
| Online Access: | https://doi.org/10.1177/25158414251341022 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AGE- MACULAR DEGENERATION AND GLAUCOMA. EPIDEMIOLOGICAL AND CLINIC-PATHOGENETIC ASPECTS
by: A. Z. Fursova, et al.
Published: (2019-02-01) -
An Assessment of Vitreous Degeneration in Eyes with Vitreomacular Traction and Macular Holes
by: Quraish Ghadiali, et al.
Published: (2017-01-01) -
Myopia and age-related macular degeneration: structural and anatomical changes of the eye
by: I. B. Alekseev, et al.
Published: (2019-08-01) -
Lutein-Containing Antioxidants in Patients with Primary Open-Angle Glaucoma and Dry Type of Age-Related Macular Degeneration
by: D. A. Dorofeev
Published: (2018-10-01) -
Visual Function and Patient Satisfaction with Multifocal Intraocular Lenses in Patients with Glaucoma and Dry Age-Related Macular Degeneration
by: Carmen Sánchez-Sánchez, et al.
Published: (2021-01-01)